Gold Health Tech Gold Health Tech
search
Available for inquiry Specification-led inquiry

Medical equipment sourcing

Pta Catheter

Reference: 566491 Cardiology
ApplicationPta
Area Of The BodyPeripheral
OptionsBalloon, Drug Eluting
Outer Diameter6 Fr, 5 Fr

Associated tags

manage_search

Product fit review

Compare the available product information with your application and purchasing requirements.

description

Documentation request

Ask which specifications, manuals, or commercial documents are available for review.

support_agent

Supplier coordination

Discuss quantity, destination, packaging, and timing before confirming suitability.

Product information

Product summary

The FREEWAYâ„¢ 035 Paclitaxel-eluting PTA balloon dilatation catheter is an over-the-wire (OTW) catheter that is specifically engineered for peripheral interventions in femoral-popliteal lesions. It is recommended for the treatment of de novo and restenotic stenosis in the iliac, femoral, iliac-femoral, popliteal, infra-popliteal, and renal arteries. Additionally, this balloon is employed for post-dilatation in the peripheral vascular system following the implantation of a stent.input:
output:
Safety and efficacy have been demonstratedinput:
output:
The utilization of Eurocors DEBs is a viable alternative to any stentless technology for the enhancement of long-term patency and may be preferable to the long-term persistence of a foreign body.input:
output:DEB has been demonstrated to be safe and effective in numerous randomized studies. It is also employed as a supportive component in treatments that require a stent.input:
output:Amorphous Coating TechnologyEurocor DEBs employ a durable non-crystalline bioshell coating that uniformly coats the balloon surface and safeguards the drug from mechanical abrasion and early wash-off, resulting in a low paclitaxel blood plasma concentration. The coating is composed of paclitaxel and shellac in a 1:1 ratio. The amorphous coating technology, which is proprietary, ensures the efficient transfer of the drug to the target vessel wall and minimizes drug loss on the way to the lesion, in accordance with our fundamental belief that the coating is the deciding factorâ„¢.input:
output:Technology for Safe Coatingsinput:
output:Eurocors DEBs provide a uniform surface that is composed of a smooth amorphous coating with Shellac and Paclitaxcel, which safeguards the drug from premature wash-off.

Continue your equipment review

Related products